Abstract: Atherosclerosis is a chronic inflammatory process. The adhesion of leukocytes to the vascular endothelium, mediated by endothelial cell adhesion molecules including vascular adhesion molecule-1 (VCAM-1), intercellular adhesion molecule-1 (ICAM-1), and E-selectin, is the pivotal early event in atherogenesis. Inflammatory cytokines could activate redox-sensitive transcription factors and induce endothelial expression of adhesion molecules, which could be inhibited to various degrees by different antioxidants suggesting the potential role of endogenous reactive oxygen species (ROS) in atherogenesis.
The vascular endothelium is a single cell layer lining the vascular wall, and plays an important role in maintaining the structure and function of vessels. It is not only a mechanical barrier between blood and vessel wall, but also is the origin of production of a variety of bioactive factors which regulate vascular tone, coagulation, cell proliferation, cell death, and inflammation [2] . The initiation of atherosclerotic lesion formation is caused by sublethal changes in endothelial function, called endothelial activation or dysfunction, in the presence of various stimulations [3] . The activated endothelium overlying lesion-prone arterial sites shows increased permeability to plasma proteins, including albumin, fibrinogen, and *Address correspondence to this author at the Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, No. 201, Sec. 2, Shih-Pai Road, Taipei, Taiwan, R.O. China; Tel: +886-2-2871-2121 ext. 3793; Fax: +886-2-2871-1601; E-mail: jwchen@vghtpe.gov.tw low-density lipoprotein (LDL). In addition, leukocytes are preferentially recruited to these lesion-prone areas by attachment to the endothelium and guided migration into the subendothelial space [3] . The process in which leukocytes react to pathogenic stimuli is a fundamental mechanism in the inflammatory response, which protects us from tissue damage and from invasion of bacteria and other intruders. However, in atherogenesis, vascular endothelium could be activated localizedly or diffusely. It may initiate monocyteendothelial interactions by endothelial expression of specific cellular adhesion molecules that interact with specific counter receptors on monocytes [4] .
Oxidant stress is a serious causative factor of vascular endothelial dysfunction and plays an important role in the pathophysiology of several vascular diseases [5] . Reactive oxygen species (ROS) are well documented to function as signaling molecules, stimulating cellular activities ranging from cytokine secretion to cell proliferation, and at higher concentrations, they can induce cell injury and death by oxidative modification of proteins and carbohydrates, lipid peroxidation, and DNA [6] . In contract, antioxidants may reduce atherogenesis and improve vascular function by inhibit oxidative modification. Furthermore, antioxidants present in the cells of the vascular wall decrease cellular production of ROS, inhibit endothelial dysfunction, and improve the biologic activity of endothelium-derived nitric oxide (NO) [3, 7] . Accumulating evidences suggest that a number of anti-oxidants or drugs with antioxidative property could reduce adhesion molecule expression and leukocyte-endothelial interactions and prevent atherogenesis. They have provided the rationale to the potential clinical benefit of these drugs or agents with antioxidant activity in preventing or treating atherosclerosis diseases. Therefore, in this review, we focused on the recent findings regarding to the inhibitory effects of drugs and agents with antioxidative property on endothelial adhesion molecule expression, a crucial step of atherogenesis.
ATHEROSCLEROSIS AND ENDOTHELIAL DYS-FUNCTION
Atherosclerosis is a vascular disease of localized inflammatory deposition of lipid within the walls of arteries. After adhering to the vascular endothelial surfaces, leukocytes could enter and accumulate in the subendothelial space, which represents one of the first stages in atherosclerosis lesion development. Leukocytes, mainly the monocyte-derived macrophages, take up lipid and form the conspicuous foam cells. Fatty streaks may develop into fibrous plaques by smooth muscle cell (SMC) migration to the intima and proliferation, as well as foam cell necrosis with deposition of extracellular cell debris, lipids, and cholesterol crystals. As fatty streaks and the lesion develops, increased necrosis and/or apoptosis of cells in the atherosclerotic plaque will lead to the formation of a central core of lipid, extracellular matrix and cell debris that is covered by a fibrous cap of variable thickness. The advanced stages of atherosclerosis are characterized by mature, fibrous plaques formed by continued proliferation of myointimal cells, necrosis of foam cells and endothelial cells (ECs), hemorrhage, mural thrombosis, and calcium deposition [8] . The process by which the plaque becomes increasingly vulnerable is at least in part mediated by an increased inflammatory activity within the lesion, which reduces the content of both cells and matrix in the fibrous cap [9] . Upon rupture, the necrotic core and the subendothelial space become exposed, which in turn initiates the formation of thrombi that may be occlusive and resulting decreased tissue blood flow and ischemia. Plaque rupture causes most of the acute symptoms associated with the atherosclerotic disease including myocardial infarction and stroke [10] . If the risk factors such as hypertension, hyperlipidemia, and smoking that causing harmful effects on the inner lining of the arteries are removed, the functional integrity of the endothelial cell layer may be restored and the vascular disease progression halted. An important object in the treatment and prevention of atherosclerosis, restenosis after balloon angioplasty, graft stenosis, and transplant vasculopathy, is therefore to promote healing of the endothelium [11] .
It was long believed that endothelial regeneration is a local process achieved by proliferation and immigration of ECs from adjacent, intact parts of the intima. However, recently, it has become evident that bone marrow-derived endothelial progenitor cells (EPCs) existing in the peripheral blood [12] take part in neovascularization, for instance in connection with wound healing and in response to ischemia [13] . EPCs have also been shown to endothelialise vascular grafts and therefore may contribute to endothelial maintenance. Animal experiments have shown that EPCs reendothelialise injured vessels and that this reduces neointimal formation, confirming that EPCs have an atheroprotective effect. On the other hand, smooth muscle cell accumulation in the neointimal space is characteristic of many forms of atherosclerosis, however the source of these cells is now thought to be from smooth muscle progenitor cells (SMPCs) rather than the adjacent media. There is evidence for the presence of SMPCs in the adventitia of animals and that SMPCs circulate in human blood. There is also data to support SMPCs contributing to neointimal formation [14, 15] .
Endothelial dysfunction induces decreased NO bioactivity and increased angiotensin II (Ang II) expression, which increase oxidative stress and expression of adhesion molecules, cytokines, and chemokines. These conditions mediate inflammation, proliferation, and thrombogenesis in vessel wall and promote atherosclerotic lesions [16] . During the development of atherosclerosis, inflammatory cytokines or growth factors promote leukocyte recruitment and then SMCs start to migrate from the tunica media and proliferate. Furthermore, vascular SMCs, vascular ECs, and leukocytes act in both a paracrine and an autocrine manner on the artery wall, promoting the progression of atherosclerosis by secreting various cytokines, including interleukins (ILs), tumor necrosis factor (TNF)-, and interferon (IFN), as well as adhesion molecules such as intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule (VCAM-1) [17] . Therapies that improve endothelial dysfunction, such as administration of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors (statins) and peroxisome proliferatior-activated receptor-(PPAR ) agonists (fibrates) have been demonstrated to reduce cardiovascular events and strokes. Both preparations suppress the production of cytokines, including IL-1 , IL-6,TNF, and adhesion molecules such as ICAM-1 and VCAM-1 [18] . They appear to have an anti-inflammatory action on the artery wall and to produce an improvement in endothelial dysfunction in addition to their lipid-controlling action [19, 20] . sion is followed by development of a more firm adhesion between leukocytes and ECs, which is postulated to be required for subsequent transmigration. The firm adhesion is primarily mediated by activation of the 2 -integrin CD18 (i.e., of polymorphonuclear neutrophils/PMNs and macrophages) or the 1 -integrin CD29 (i.e., of lymphocytes) and/or upregulation of the endothelial counter receptors, the immunoglobulin super-family of adhesion molecules including ICAM-1, ICAM-2, and VCAM-1. The firm adhesion of leukocytes onto the vascular endothelial surface is regarded to be an essential step leading to transmigration through the intercellular junctions (diapedesis). Under pathological conditions, in which localized stimuli such as cytokines cause excessive and prolonged leukocyte and endothelial cell activation responses, excessive extravasation may occur, resulting in tissue damage [24] .
ADHESION MOLECULES, INFLAMMATION, AND OXIDATIVE STRESS
The recruitment of leukocytes to sites of inflammation is governed by the magnitude of endothelial adhesion molecule expression. The high density of endothelial adhesion molecule that is needed to sustain the large number of leukocytes that infiltrate inflamed tissue is dependent on de novo protein synthesis. A variety of endotoxins, cytokines, and oxidants are known to induce transcription-dependent synthesis of different endothelial adhesion molecules, including ICAM-1, VCAM-1, E-selectin, and P-selectin [5] . For example, ICAM expression is induced by cytokines, such as TNF-, IFN-, IL-1 , or lipopolysaccharide (LPS); or by adherence to extracellular matrix [25] . Similarly, oxidant mediated increased PMN adhesion to endothelium was associated with increased expression of ICAM-1 [26] .
There is clear indication that oxidant stress promotes increased leukocyte adhesion to vascular endothelium [27, 28] . Oxidant increases PMN adhesion to endothelium was associated with increased expression of adhesion molecules [28, 29] . These results suggest that leukocyte adhesion is mediated by adhesion molecule expression on the endothelium in a mechanism involving oxidative stress.
Risk factors for atherosclerosis, such as hypertension and hyperlipidemia, are also associated with increased generation of ROS, and cigarette smoking and DM enhance oxidative status [30] . At the molecular level, signaling in response to pro-atherogenic agents requires as well as causes generation of ROS [30] . It has been identified that cytokines, including TNF-, IFN-, IL-1, IL-6, and Ang II [31, 32] , stimulate intracellular generation of ROS. Oxidized-LDL (oxLDL) have also been shown to increase intracellular ROS generation [33] . In addition, growth factors, such as platelet-derived growth factor (PDGF), epidermal growth factor (EGF), and vascular endothelial growth factor (VEGF), all greatly induce intracellular ROS generation [34] . NAD(P)H oxidases, xanthine oxidase, uncoupled NO synthase (NOS), and mitochondria are predominate important sources of ROS in the vessel wall. Although various ROS have pathological roles, some serve as important signaling molecules that modulate vascular tone, growth, and remodeling [35] . The NAD(P)H oxidase enzymes represent a major source of ROS in vascular cells. The Nox proteins represent the catalytic subunits of these enzymes and vary in terms of their mode of activation and need for cofactor activation [36] . Pathological stimuli, such as inflammatory cytokines, Ang II, endothelin-1, thrombin, and catecholamines acutely activate the NAD(P)H oxidases in vascular SMCs and ECs [35] . Another important source of ROS in mammalian cells is the xanthine oxidase [37] . Xanthine oxidase uses oxygen as an electron acceptor to form superoxide and H 2 O 2 . Xanthine oxidase can produce ROS and affect endothelial function in humans in the setting of pathology, possibly caused by stimulation of xanthine oxidase expression by inflammatory cytokines or other stimuli in these conditions [38, 39] . Uncoupled endothelial NOS also contribute to vascular ROS generation. The normal product of this enzyme is NO; however, in the absence of either L-arginine or tetrahydrobiopterin (BH 4 ), the NOS are incapable of transferring electrons to L-arginine and begin to use oxygen as a substrate for superoxide formation [40] . Uncoupling of endothelial NOS has been demonstrated in various pathophysiological conditions including diabetes, hypercholesterolemia, and hypertension [35] . In other organs and tissues, the mitochondrial electron transport chain represents the predominant source of ROS. There is ample evidence that mitochondria play an important role in vascular ROS production. Stimuli such as high glucose, cyclic strain, leptin, and cigarette smoking have been shown to damage aortic mitochondrial DNA and alter mitochondrial enzyme activity [35] . The mechanism for the generation of intracellular ROS also appears to involve other sources or multiple biochemical enzyme systems such as cytochrome P450, amine oxidase, cyclooxygenase (COX), lipoxyogenase, oxalate oxidase, and peroxidases [41, 42] (Fig. 2) .
OXIDATIVE STRESS AND REDOX-SENSITIVE TRANSCRIPTION PATHWAYS
Oxidative stress has been identified throughout the process of atherogenesis, beginning at the early stage when endothelial dysfunction is unapparent [43] . In general, increased production of ROS may affect several fundamental mechanisms that contribute to atherogenesis such as oxidation of LDL, endothelial cell dysfunction, vascular SMC growth, and monocytes migration [44] . A number of studies suggest that ROS oxidize lipids and that the modified LDL is a more potent pro-atherosclerotic mediator than the native LDL; oxLDL causes activation of the ECs lining the arterial wall, resulting in the expression of several adhesion molecules that facilitate the adhesion of monocytes/macrophages [45, 46] . An important characteristic of endothelial dysfunction is impaired synthesis, release, and activity of endotheliumderived NO. It has been demonstrated that endothelial NO inhibits several processes involved in atherogenesis. Inactivation of NO by superoxide anion limits the bioavailability of NO and leads to nitrate tolerance, vasoconstriction, and hypertension as well as atherosclerosis [47] . Moreover, adhesion of monocytes to ECs has been linked to the impaired NO and increased ROS generation.
ROS stimulate the expression and release of several proatherogenic and inflammatory mediators, but less is known regarding the specific intracellular signaling pathways by which ROS act [48] . Some studies suggest that the function and activity of intracellular signals are regulated by ROS. These studies link the cellular oxidative state to specific mitogen-activated protein kinases (MAPKs), such as p38 MAPK [48] , extracellular signal-regulated kinase (ERK) 1/2, and cJun N-terminal kinase (JNK) [49] signaling pathway. Although MAPK plays a central role in ROS-mediated signal transduction in cardiovascular diseases, other protein kinases (such as tyrosine kinases) are also involved in ROS-mediated changes in vascular cells [49] . In addition to regulating enzyme activity, ROS participate in signal transduction by generating classic second-messengers (calcium and lipid mediators) that transmit signals to intracellular mediators in both the cytoplasm and nucleus [49] .
The final step in the ROS-mediated signaling pathway usually involves the activation of transcription factors, which are proteins that are transported to the nucleus upon activation and trigger target gene expression. Nuclear factor-B (NF-B) is an inducible transcription factor that is a likely target for ROS signal transduction. Cytosolic NF-B can be activated by a variety of stimuli including cytokines, physical stress such as ultraviolet, ionizing radiation, and ROS. The recognition sequence for NF-B is present in genes, Fig. (2) [59] .
Inhibitors of NF-B and AP-1 activation or nuclear translocation have been shown to attenuate cytokines, LPS, or oxidants-induced adhesion molecule expression [60] . In addition, recent evidences showed that the STAT-1 and STAT-3 could be new molecular targets of anti-inflammatory treatment [61, 62] . These findings provide rationale for manipulation of intracellular singnalings as well as NF-B, AP-1, and/or STAT systems as mean of controlling transcriptiondependent cellular events that lead to leukocyte recruitment (Fig. 3) .
ANTIOXIDANTS AND ADHESION MOLECULE EX-PRESSION
In normal conditions, numerous cellular antioxidant systems exist to defend against oxidant stress and maintain the redox balance of the cell. ROS could be scavenged from the cell by enzymatic systems including superoxide dismutase (SOD), catalase, and glutathione peroxidase (GPx), etc., or the nonenzymatic system including vitamin E ( -tocopherol), vitamin C (ascorbic acid), GSH, uric acid, biliverdin, and bilirubin, etc. In addition to traditional antioxidant enzymes, recent findings showed that other biochemical enzymes, including NOS, HO-1, thioredoxin, and paroxonase, also exhibited antioxidative property in the defend system against oxidative stress [63] [64] [65] . The nonenzymatic antioxidants also involved in the defend system. Uric acid, as well as GSH, acts as a direct endogenous scavenger of hydroxyl radicals. Ascorbic acid scavenges free radicals and reduces them into H 2 O 2 , which can be further catalyzed by catalase to form water and oxygen. -tocopherol can transfer a hydrogen atom with a single electron to free radicals, thus removing the radicals before they can interact with cell membrane proteins or generate lipid peroxidation [42] . Biliverdin and bilirubin also have antioxidant properties, efficiently scavenging reactive oxygen species and inhibiting lipid peroxidation [66, 67] . Two small molecules, NO and CO, were recently placed importance on their influences electron-transport reactions producing antioxidant effects when in an appropriate concentration [68, 69] .
Since ROS are widely known to be involved in the progression of atherosclerosis, it's not surprising that antioxidant therapies are one of the most effective and promising strategies against atherogenesis. To date, there are many drugs that against cardiovascular diseases have exhibited antioxidant effects; these drugs simultaneously inhibit endothelial adhesion molecule expression, such as aspirin, probucol, HMG-CoA reductase inhibitors, angiotensin receptor blockers (ARBs), angiotensin converting enzyme (ACE) inhibitors, peroxisome proliferator-activated receptor and (PPAR and PPAR ) ligands, calcium channel blockers, -adrenergic blockers, etc. In addition to the drugs clinical used, there are a number of agents also exhibiting antioxidative proprieties with anti-atherogenesis effects, including herbal medicines and dietary supplements, or some chemical composition derived from them. Then, base on recent studies including our own, the role of these antioxidative drugs and agents that inhibiting endothelial adhesion molecule expression and atherogenesis will be briefly described in the following paragraphs and in Table 1 .
Clinical Cardiovascular Drugs with Antioxidative Property

Aspirin
Aspirin (acetylsalicylic acid) is one of the most widely used drugs worldwide. It is well accepted that beneficial effects of aspirin in secondary prevention of myocardial infarction are primarily caused by irreversible inhibition of platelet COX-1 and the resulting inhibition of thromboxane A 2 formation [70] . Sodium salicylate (an aspirin derivative), serving as a chemical trap for hydroxyl radicals has been shown to ameliorate hypoxia/reoxygenation injury in several tissues [71] . Salicylate blocked the TNF--induced increase in mRNA levels of adhesion molecules and inhibited TNF--induced surface expression of VCAM-1 and ICAM-1 with higher doses required to inhibit E-selectin expression. Treatment of endothelial cell monolayers with sodium salicylate inhibited transendothelial migration of neutrophils [72] . Some other nonsteroidal antiinflammatory drugs (NSAIDs), such as indomethacin, diclofenac, and ketoprofen, but not steroids, were also found to strongly inhibite the neutrophilendothelial cell attachment [73] .
High concentrations of salicylates have been shown to modulate MAPK cascade and inhibitory effects of salicylates have been observed on several nuclear transcription factors.
Among transcription factors, the focus of research has been the interaction between salicylates and NF-B. Inhibition of the NF-B pathway by aspirin and salicylate has been shown [74] and several subsequent studies [72, 75, 76] . AP-1 has been also reported to be affected by salicylates [77] , it is activated by several pro-inflammatory stimuli such as TNF-, and regulates the expression of genes involved in the immune and inflammatory responses, overlapping in several instances with the target genes of NF-B [70] . These evidences showed the clinical importance of high-dose salicylates in inflammation may be due, in part, to the ability to prevent expression of inducible adhesion molecules and recruitment of leukocytes.
Probucol
Probucol is a potent LDL-lowering agent with powerful antioxidant property that effectively inhibits the oxidative modification of LDL independent of its lipid-lowering effect. Probucol and its analogue without lipid lowering effect have been shown to prevent the progression of atherosclerosis in hypercholesterolemic rabbits [78, 79] and downregulates Eselectin expression on cultured human vascular ECs [80] . By exerting antioxidant effect, it may inhibit VCAM-1 and MCP-1 expression and inhibit human aortic SMC proliferation [81] . Recently, probucol was shown to inhibit intimal thickening after balloon injury by promoting the vascular remodeling and the regeneration of functional endothelium [82, 83] .
Pretreatment of HUVECs with probucol significantly reduced the expression of VCAM-1 on HUVECs induced by oxLDL, but the effect on ICAM-1 was much less evident [84] . The mechanisms underlying the protective effects of probucol have been studied in rabbits and involve a significant decrease in neointimal proliferation rates in apparent correlation with diminished activation of MAPKs and protein kinase-C (PKC) [85] . Inhibition of NF-B but not AP-1 pathway by probucol in human aortic endothelial cells (HAECs) has been shown in our previous studies [86, 87] .
HMG-CoA Reductase Inhibitors
The HMG-CoA reductase inhibitors (statins) are potent lipid-modifying agents. There is overwhelming evidence from clinical studies that reducing plasma LDL levels with statins results in a markedly lower risk of cardiovascular events related to atherosclerosis [20] . It has been suggested that the anti-atherosclerotic effect of statins may be independent of their LDL-lowering effect, among which is their ability to decrease ROS generation [88, 89] . Statins block expression of protein subunits of p22 phox and gp91 phox which determine activity of NAD(P)H oxidases and expression of GTP-ase [NAD(P)H activator]. This leads to suppression of activity of pro-oxidant enzyme systems [NAD(P)H oxidase, xanthine oxidase, oxidase activity of endothelial NOS] and diminishment of production of most aggressive free radicals-superoxide anion and peroxinitrite. Hyperproduction of these radicals is associated with lowering of NO level and augmented NO destruction, the state of oxidative stress and endothelial dysfunction. Statins increase expression of enzymes with antioxidant properties (catalase and paroxonase), augment resistance of LDL to oxidation. Thus statins are considered as powerful antioxidants [88, 89] . Different [90] . Pretreatment of ECs with simvastatin or atorvastatin reduced TNF--or oxLDL-induced expression of adhesion molecules. Statins inhibited expression of VCAM-1 and ICAM-1 through effects on redox-sensitive NF-B [46, 91] but not AP-1 [46] . NO was also found to mediate the effect of fluvastatin on ICAM-1 and platelet-endothelial cell adhesion molecule-1 (PECAM-1) expression on human ECs [92] . Another study showed that statins act directly on ECs to inhibit expression of adhesion molecules and neutrophil adhesion mediated by high glucose through increasing endothelial NO production [93] . However, in contrast and interestingly, it has been shown that lovastatin-stimulated superinduction of E-selectin, ICAM-1 and VCAM-1 in TNF--activated human vascular ECs [94] . Pretreatment with simvastatin, fluvastatin, or pravastatin potentiated the TNF-and LPS-induced expression of E-selectin and VCAM-1 [95] . The effects of statins on endothelial adhesion molecule expression are still controversial and remain further examination.
Peroxisome Proliferatior-Activated Receptor Agonists
PPAR is a member of the steroid/thyroid-hormone receptor superfamily [96] . It is a major transcription factor for peroxisome proliferation and controls the expression of various genes. Three types of PPARs have been identified: PPAR , PPAR (the type/NUC1), and PPAR . The target genes of these PPARs are generally involved in lipid metabolism. Synthetic ligand/activators for PPAR are already in widespread clinical use, and the results of studies have confirmed that their administration is associated with marked fluctuations in atherosclerosis risk factors such as blood sugar, triglyceride (TG) and body weight [97] . These findings illustrate that PPAR is associated with lipid metabolism, while PPAR is concerned with carbohydrate metabolism [18] .
The ligands of PPAR (fibrates) increase lipoprotein lipase (LPL) activity and suppress the secretion of TG-rich lipoproteins from the liver and increase the production of HDL. PPAR is a transcription factor, which binds to the consensus sequence of the promoter region of LPL or other enzymes associated with the -oxidation of fatty acids. Fenofibrate, a ligand/activator of PPAR , suppresses the induction of IL-6 by IL-1 in human vascular SMCs and induces the expression of the COX-2 gene through NF-B signal transmission by IL-1 [98] . It has been reported SOD was activated partly through the PPAR response element [99] , it is possible that the proliferation of peroxisomes may increase the expression of SOD. Previous investigation showed that p22 phox mRNA expression levels in vascular ECs are significantly reduced by bezafibrate administration. Thus, the antiatherosclerotic action of fibrates could possibly be partly attributable to attenuation of excessive NAD(P)H oxidase activity in active vascular ECs [100] .
The ligands of PPAR were initially developed to affect glucose and lipid metabolism. These agents, such as rosiglitazone and pioglitazone, are widely used in the treatment of type II diabetes. Recently, PPAR ligands have been identified as potent antioxidants [100] . Thiazolidinedione reduces the size and number of atherosclerotic lesions in the vessel wall by modulating foam cell formation and inflammatory responses of macrophages [101] . A recent study shows a significant vascular protective effect of rosiglitazone in hypercholesterolemic rabbits, most likely by the attenuation of oxidative stress, and this endothelial protective effect of rosiglitazone may reduce leukocyte accumulation in vascular walls and contribute to its anti-atherosclerotic effect [102] . Pioglitazone decreases TNF--mediated apoptosis in human coronary artery ECs by reducing ROS formation [103] . Thus, PPAR-ligands have the potential for the treatment of atherosclerosis and type II diabetes [104] .
Previous studies showed that PPAR activators 15d-PGJ 2 , Wyeth 14643, ciglitazone, and troglitazone, but not BRL 49653, partially inhibit the induced expression of VCAM-1 and monocyte binding to HAECs activated by phorbol 12-myristate 13-acetate (PMA) or LPS [105] . PPAR activation significantly suppressed the expression of vascular adhesion molecules in ECs and the ensuing leukocyte recruitment. Furthermore, constitutive activation of PPAR resulted in simultaneous repression of AP-1 and NF-B activity [106] . Pioglitazone inhibited the expression of VCAM-1 protein and mRNA on activated HUVEC after IL-1 stimulation. However, it showed little effect on the expression of ICAM-1 and E-selectin [107] . PPAR agonists, thiazolidinedione class drugs (TZDs), or 15d-PGJ 2 were capable of activating diacylglycerol kinase, resulting in attenuation of diacylglycerol (DAG) levels and inhibition of PKC activation. The suppression of DAG-PKC signaling pathway was functional linkage to the anti-inflammatory properties of PPAR agonists in ECs, characterized by the inhibition of proinflammatory adhesion molecule expression and adherence of monocytes to the activated EC induced by high glucose [108] .
Calcium-Channel Blockers
The main objectives of treating hypertension are to prevent the progression of hypertension-related atherosclerosis, thereby resulting in a decreased incidence of cerebrovascular disorder, ischemic heart disease, and renal dysfunction. Among the available antihypertensive drugs, there is growing interest in the use of ACE inhibitors, calcium-channel blockers, and adrenergic blockers, because of their direct actions on the arterial walls in addition to their antihypertensive effects.
Intracellular calcium plays an important role in intracellular signal transmission. Calcium-antagonists suppress calcium influx mainly through voltage-dependent calciumchannels. It has been shown that addition of calcium-channel blocker, lacidipine, to HUVECs significantly reduced the expression of ICAM-1, VCAM-1, and E-selectin induced by TNF-alone or with oxLDL; the reduction in adhesion molecule expression caused by lacidipine was paralleled by a significant fall in NF-B translocation [109] . Verapamil selectively inhibited cytokine-induced protein and mRNA levels of VCAM-1, and suppressed cell adherence between TNF--stimulated ECs and mononuclear cells (MNCs) suggesting that verapamil may suppress immune response partly via inhibition of VCAM-1 expression [110, 111] . Pretreatment of HAECs with benidipine significantly suppressed cytokine-induced VCAM-1 and ICAM-1 mRNA and protein expression, resulting in reduced adhesion of THP-1 monocytes [112] . Nifedipine significantly inhibited TNF--induced upregulation of VCAM-1 mRNA levels in HUVECs and blocked lymphoblastic cell adhesion to TNF--exposed HUVEC [113] . These studies provide beneficial aspects of calcium-channel blockers on atherogenesis and endothelial adhesion molecule expression.
Angiotensin II Receptor Blockers and AngiotensinConverting Enzyme Inhibitors
There is activation of rennin-angiotensin system in many hypertensive patients. Activation of rennin-angiotensin system with the formation of Ang II and subsequent activation of Ang II receptors, mainly type I receptors (AT1R), has been implicated in atherogenesis [114] . Increased expression of ACE and Ang II has been observed in areas of inflammation in vascular lesions both in animal models and in humans [115, 116] . Ang II can exert multiple pro-atherogenic effects on vascular ECs and SMCs by activating AT1R. Ang II increases NAD(P)H oxidase activity in macrophages via AT1R activation [117] and stimulates NAD(P)H oxidase activity and increases ROS production in vascular SMCs [118] . Induction of NAD(P)H oxidase expression and ROS generation as well as MAPK activation were in response to Ang II in mice [119] and human ECs [120] . There is rapidly growing evidences showed Ang II-induced oxidative stress plays an important role in Ang II-mediated cellular responses. An in vivo study showed that the pro-atherogenic effect of intravenous infusion of Ang II is attenuated by coinfusion of vitamin C [121] . This idea is further supported by several findings showing that blockade of ARBs, such as losartan and candesartan, attenuates Ang II-induced oxidative stress and proatherogenic effects [122, 123] . ARBs and ACE inhibitors are widely used to treat patients with hypertension and/or congestive heart failure by blocking the effect of Ang II or its formation. Recent studies show that Ang II is also a strong stimulus for ROS generation [31, 32, 124] , and ARBs as well as ACE inhibitors inhibit the expression of pro-atherogenic factors by decreasing ROS production in vascular ECs and in animal models [114, 125, 126] .
As further evidence for the role of Ang II in atherogenesis, ACE inhibitors as well as ARBs have been shown to decrease the progression of atherosclerosis in a variety of hyperlipidemic animals [123, 127] . Consistent with the concept of slowing of progression of atherosclerosis, these agents also decrease the markers of inflammation and LDL oxidation in the atherosclerotic regions [123, 127] . Further endothelial dysfunction can be reversed by short-and longterm ARBs [128, 129] . This cardioprotective effect is associated with increased NO bioavailability [128, 130] , reduced oxidative stress, and antiinflammatory modulation of cell surface and circulating adhesion molecules [131, 132] .
Administration of ACE inhibitors or ARBs has been reported to inhibit migration of inflammatory cells and expression of adhesion molecules, cytokines, and chemokines in atherosclerosis and to relieve hypertension in experimental animal models [133] . In rat models of hypertension induced by angiotensin infusion, significant infiltrations of monocytes and increased expression of VCAM-1 in aortas has been reported [134] . Together with the pro-arteriosclerotic effects of Ang II on the arterial wall, these studies suggest that ACE inhibitors exert its effect of risk reduction in cardiovascular and cerebrovascular events by blocking Ang II signaling, which improves endothelial dysfunction and thus prevents progression or destabilization of atherosclerotic lesions. A number of recent studies in hyperlipidemic human atherosclerotic tissues have confirmed the upregulation of ACE and AT1R, particularly in the regions that are prone to rupture [42] . Recently, ARBs (losartan and olmesartan) were shown to inhibit the expression of adhesion molecules; ACE inhibitors (zofenopril and alacepril) inhibited expression of adhesion molecules by mechanisms involving reduction of ROS [125, 135] . In addition, both the inhibition with ACE inhibitors or ARBs and the treatment of hyperlipidemia with statins have been shown to be effective in reducing endothelial dysfunction, monocyte adhesion, and SMC migration as well as atherogenesis [114] .
-Adrenergic Blockers
-adrenergic blockers ( -blockers) are an important class of drugs for the treatment of various heart diseases [136] . Carvedilol is a novel, multiple-action drug recently approved for treatment of hypertension and also for treatment of con-gestive heart failure [137] . In extensive clinical trials conducted worldwide, carvedilol given once daily has been shown to be effective in lowering blood pressure [138] . Carvedilol is a potent and competitive antagonist of 1 -, 2 -, and 1 -adrenoceptors [139] . It is devoid of intrinsic sympathomimetic activity at 1 -and 2 -adrenoceptors [139] . Carvedilol showed potent antioxidant properity, deriving its antioxidant activity from its carbazole moiety. Extensive studies in a variety of test systems, including physicochemical, biochemical, cellular, and in vivo models, establish the ability of carvedilol to scavenge oxygen-derived free radicals [137, 138] . Neutrophils accumulate at the site of injury in all tissues and organs in response to a wide array of insults. In experimental models of myocardial ischemia and reperfusion in several different species, carvedilol significantly reduced neutrophil infiltration [140, 141] . In contrast, although an equivalent -blocking dose of propranolol reduced infarct size, it did not reduce the neutrophil influx and, correspondingly, the reduction in infarct size was significantly smaller than that produced by carvedilol. It is conceivable, then, that the higher degree of cardioprotection produced by carvedilol relative to other -blockers may be due, in part, to inhibition of the inflammatory response to ischemic injury and the reduction in trafficking of activated neutrophils [138] .
The mechanisms by which carvedilol suppresses inflammatory cell infiltration into ischemic myocardium are not fully understood. Suppression of neutrophil infiltration by carvedilol is most likely the consequence of some mechanism other than -blockade because propranolol does not inhibit neutrophil infiltration into the ischemic myocardium. It has recently been demonstrated that carvedilol inhibits neutrophil adhesion to ECs by suppressing the expression of ICAM-1 [142] . Down-regulation of ICAM-1 expression may contribute to cardioprotection by blocking the ability of neutrophils to translocate from body circulation to injured or ischemic myocardial tissue, thereby limiting neutrophilinduced tissue injury [138] . Our recent study showed that carvedilol reduces TNF--stimulated endothelial adhesiveness to human MNCs by inhibiting intracellular ROS production, transcription factor (NF-B and AP-1) activation, and VCAM-1 as well as E-selectin expression, suggesting its potential role in preventing atherogenesis. Interestingly, propanolol, prazosin, or both did not alter the expression of adhesion molecules [143] . Another -blocker, celiprolol, was also shown to suppress VCAM-1 expression because of inhibition of oxidative stress, NF-B, and signal transduction, while increasing endothelial NOS via stimulation of the PI3K-Akt signaling pathway and improving cardiovascular remodeling [144] .
Tranilast
N-(3,4-dimethoxycinnamoyl) anthranilic acid (tranilast)
is an anti-inflammatory drug with several mechanisms of action. Initially, it was found to inhibit the antigen-induced release of histamine from mast cells [145] . Therefore, it was developed for the treatment of allergic diseases such as bronchial asthma and allergic rhinitis. Subsequently, other biological effects of tranilast have been suggested, such as inhibition of oxygen free radicals, cytokines, leukotrienes, prostaglandins, and COX-2 expression [146] . In several models of inflammatory disease, tranilast is anti-proliferative and inhibits collagen deposition [147] [148] [149] . Recently, it has been proposed that tranilast inhibits atherosclerosis in animal models [150, 151] .
Tranilast could inhibit vascular inflammation but the relevant anti-inflammatory mechanisms are not fully understood. The effects of tranilast on NF-B-dependent endothelial cell adhesion molecule expression and transcriptional regulation has been studied. TNF--induced VCAM-1, ICAM-1, and E-selectin surface expression on HUVECs was inhibited by tranilast. The inhibition of NF-B dependent gene transcription was considered to contribute to the antiinflammatory effects of tranilast [152] .
Cilostazol
Cilostazol is a platelet aggregation inhibitor and vasodilator which is useful for treatment of ischemic symptoms of peripheral vascular disease [153] . Cilostazol is a specific inhibitor of cAMP phosphodiesterase, and thus it elevates intracellular levels of cAMP [154] . Besides its anti-platelet and vasodilator properties, cilostazol has been shown to inhibit vascular SMC proliferation in vitro as well as to suppress neointimal formation in balloon-injured rat carotid artery [155, 156] . In addition, cilostazol has been demonstrated to prevent restenosis after percutaneous transluminal coronary angioplasty [157, 158] .
The effect of cilostazol on the expression of VCAM-1 in cultured vascular ECs has been examined. Cilostazol strongly inhibited TNF--induced expression of VCAM-1 protein and mRNA. In addition, cilostazol reduced TNF--induced human monocytic cell line, U937 cell adhesion to the vascular ECs. Cilostazol repressed TNF--induced increase in binding of NF-B to its recognition site of VCAM-1 promoter indicating that cilostazol repressed VCAM-1 gene transcription via inhibiting NF-B binding to its recognition sequence [159] . Another group has examined the direct effects of tranilast on endothelial-neutrophil adhesion and expression of endothelial adhesion molecules induced by high glucose and found that cilostazol may act directly on ECs to inhibit expression of adhesion molecules and neutrophil adhesion induced by high glucose through increasing NO production [160] .
Herbal Medicines with Antioxidative Property
Ginkgo Biloba
Ginkgo biloba extract (GBE or EGb761), a defined complex mixture containing 24% ginkgo flavone glycoside and 6% terpenlactones (ginkgolides, bilobalide) that is extracted from Ginkgo biloba leaves, has commonly been used as a therapeutic agent for cardiovascular and neurological disorders [161] . A number of mechanisms have been proposed for the beneficial actions of GBE; these include increased blood flow, inhibition of platelet aggregation, and its antioxidant capacity [161] . In addition, GBE provides protection in model systems of oxidative stress, including cardiac ischemia-reperfusion injury [162] . It is then suggested that the pharmacological effects of GBE are closely related to its antioxidant ability to scavenge free radicals [163, 164] .
TNF--induced endothelial adhesiveness toward monocytes and neutrophils has been studied using bovine cerebral microvascular endothelial cells (BCMEC) showed the inhibition of GBE on monocyte and neutrophil adhesion to BCMEC was mediated through the suppression of E-selection expression [165] . Moreover, our previous study showed that GBE could reduce cytokine-stimulated endothelial adhesive-ness by downregulating intracellular ROS formation, NF-B and AP-1 activation, and adhesion molecule expression in HAECs [86] , supporting the notion that the natural com-pound Ginkgo biloba may have potential implications in clinical atherosclerosis disease.
Salvia Miltiorrhiza (Salvianolic Acid B and Protocatechuic Aldehyde)
Salvia miltiorrhiza Bunge is a herb often used in popular folk medicine in China, Japan, and Taiwan for the treatment of cardiovascular disorders (called blood stasis in traditional Chinese medicine). Treatment with Salvia miltiorrhiza reduces the intimal thickness in the injured carotid artery in rats and inhibits the proliferation of isolated rabbit arterial SMCs [166] . Salvianolic acid B , a water-soluble polyphenolic antioxidant isolated from the roots of the same plant, scavenges 1,1-diphenyl-2-picryhydrazyl (DPPH) radicals and inhibits LDL oxidation more effectively than the antioxidant, probucol [167] . A salvianolic acid B-rich fraction of a Salvia miltiorrhiza extract also inhibits LDL oxidation in vitro and ex vivo and reduces atherosclerosis in hypercholesterolemic rabbits [167] .
Our previous study firstly demonstrated that Salvia miltiorrhiza extract and salvianolic acid B attenuated the expression of VCAM-1 and ICAM-1, and this effect was mediated by partial blockage of NF-B activation. Both agents also significantly inhibited adhesion of U937 to HAECs [87] . Other studies gave simulate results that the water-soluble extract of Salvia miltiorrhiza inhibited the adhesion of neutrophils by suppressing the expression of Eselectin, ICAM-1, and VCAM-1 [168] . Another study also showed that the inhibition of the aqueous extract of Salvia miltiorrhoza on the expression of adhesion molecules may result from its blocking activation on NF-B and the inhibitory effect was attenuated by inhibition of intracellular GSH synthesis [169] . More recently, protocatechuic aldehyde (another potent water-soluble antioxidant derived from Salvia miltiorrhiza), appeared to inhibit TNF--stimulated VCAM-1 and ICAM-1expression in HUVECs through a mechanism that involves NF-B and AP-1 [170] . These evidences may imply the inhibition of adhesion molecule expression by which Salvia miltiorrhiza exerts its beneficial effect preventing the progress of atherosclerosis.
Magnolia Officinalis (Magnolol and Honokiol)
Magnolia officinalis, a Chinese medicinal herb, has long been used for the treatment of fever, headache, anxiety, diarrhea, asthma, and stroke. Magnolol, a compound purfied from this herb, has vascular smooth muscle relaxant activity [171] , an antithrombotic effect [172] , and anti-inflammatory and analgesic effects [173] . A number of other pharmacological effects of magnolol have also been found, including inhibition of neutrophil adherence [174] , prevention of ischaemic-reperfusion injury [175] , and, most importantly, strong antioxidant activity [172, 176] .
Since magnolol inhibits acyl-CoA: cholesterol acyltransferase, which catalyzes cholesterol esterification and facilitates the accumulation of intracellular cholesterol, both of which are involved in the pathogenesis of atherogenesis, it can be considered as a cholesterol lowering agent for the treatment of hypercholesterolaemia and atherosclerosis [177] . Moreover, it has been shown to effectively prevent neointimal hyperplasia in the balloon-injured aorta of cholesterolfed rabbits and inhibit TNF--induced nuclear translocation of NF-B p65 and thereby suppresses expression of VCAM-1, resulting in reduced adhesion of leukocytes [178] . Furthermore, in vivo, magnolol attenuates the intimal thickening and TNF-and VCAM-1 protein expression seen in the thoracic aortas of cholesterol-fed rabbits [179] . Honokiol, another compound purified from Magnolia officinalis, was also shown to inhibit cerebral ischemia-reperfusion injury its antioxidative and anti-inflammatory actions through, at least in part, limiting lipid peroxidation and reducing neutrophil activation/infiltration by interfering firm adhesion, ROS production, and calcium overloading that may be primed/ activated during injury [180] . These informations suggest that Magnolia officinalis has anti-inflammatory properties with antioxidant effects and may play important roles in the prevention of atherosclerosis and inflammatory responses.
Curcuma Longa (Curcumin)
Curcumin (diferuloylmethane) is a major chemical component of turmeric (Curcuma longa) and is used as a spice to give a specific flavor and yellow color to curry. It is also used as a cosmetic and in some medical preparations and has been shown to possess potent antioxidant [181] . Curcumin has been shown to display anti-inflammatory and anticarcinogenic properties [182, 183] . The anti-inflammatory effects of curcumin are most likely mediated through its ability to inhibit COX and lipoxygenase [184] . Recently, curcumin has also been shown to inhibit the activation of NF-B and AP-1 [185, 186] . Exposure of bovine aortic ECs to curcumin increase HO-1 mRNA, protein expression and enzyme activity indicating that curcumin is a potent inducer of HO-1 in vascular ECs and that increased HO-1 activity is an important component in curcumin-mediated cytoprotection against oxidative stress [187] .
It has been found that pretreatment of ECs with curcumin completely blocked their adhesion to monocytes, as well as the cell surface expression of ICAM-1, VCAM-1, and Eselectin. TNF--activated NF-B was inhibited by pretreatment with curcumin, indicating that NF-B inhibition may play a role in the suppression of expression of adhesion molecules [188] . Another group demonstrated that out of three compounds, viz diferuloylmethane, p-coumaroylferuloylmethane and di-p-coumaroylmethane, present in the ethyl acetate extract of Curcuma longa, diferuloylmethane is most potent in inhibiting TNF--induced expression of ICAM-1, VCAM-1 and E-selectin on HUVECs [189] . These results demonstrate that the anti-inflammatory properties of Curcuma longa may be attributable, in part, to inhibition of leukocyte recruitment.
Astragalus Membranaceus (Saponin Astragaloside IV)
The saponin astragaloside IV (AS-IV), purified from the Chinese medical herb Astragalus membranaceus Bunge, has been shown to have anti-inflammatory effects in vivo [190] . Astragalus membranaceus is a herbal medicine that has been used clinically in stroke patients in China for decades, its potential neuroprotective effect against ischemic brain injury has been experimentally tested in a murine model of focal cerebral ischemia/reperfusion produced by transient middle cerebral artery occlusion. AS-IV treatment also decreased the levels of malondialdehyde, an indicator of lipid peroxidation, and increased the levels of the antioxidant enzymes GPx and SOD in ischemic tissues suggesting that the antiinfarction effect by AS-IV may be derived at least in part from its antioxidant properties [191] .
The effect of AS-IV has been investigated on cytokineand LPS-stimulated expression of adhesion molecules in and leukocyte adhesion to ECs. AS-IV significantly reduced the adhesion promoting activity of LPS-stimulated HUVECs for PMNs and the monocytic cell line THP-1. Furthermore, AS-IV decreased the LPS-induced expression of E-selectin and VCAM-1 on the surface of HUVECs, whereas the expression of ICAM-1 was not affected. AS-IV also inhibits TNF--induced VCAM-1 expression. AS-IV completely abolished LPS-and TNF--induced NF-B activation in ECs. The ability of AS-IV to inhibit the NF-B pathway might be one underlying mechanism contributing to its antiinflammatory potential in vivo [192] .
Tanacetum Parthenium (Parthenolide)
The extracts of the aromatic herb feverfew (Tanacetum parthenium) and one of its bioactive components, parthenolide, have anti-inflammatory properties in vivo and in vitro [193] . Parthenolide could bind directly to and inhibit I-B kinase (IKK ), the kinase subunit known to play a critical role in cytokine-mediated signaling [194] . It has been reported that a strong intracellular antioxidant activity of the sesquiterpene lactone parthenolide by an increase of total GSH [195] .
In ECV 304 cells, L-3,5,3'-triiodothyronine (T3) markedly increased ICAM-1 protein expression. Parthenolide exhibited a repressive effect on the expression of the protein ICAM-1 stimulated by T3 [196] . Parthenolide was shown to block IL-4-induced expression of the endothelial VCAM-1 and inhibit the STAT6 DNA-binding activity in IL-4-stimulated ECs [197] . Recently, parthenolide was shown to abolish C-reactive protein (CRP)-induced VCAM-1 mRNA expression and NF-B activation [198] . The modulation of adhesion molecule expression may be an additional mechanism by which Tanacetum parthenium mediates anti-inflammatory effects.
Tripterygium Wilfordii (Triptolide)
Triptolide is a diterpenoid triepoxide purified from a Chinese herb Tripterygium Wilfordii Hook F (TWHF) [199] . Its potential value was recognized by the Western medicine after investigators observed the effectiveness of TWHF in the treatment of leprosy and rheumatoid arthritis [199] . Triptolide has been identified as the major component responsible for the immunosuppressive and anti-inflammatory effects of TWHF. Currently available data suggest that triptolide is a promising immunosuppressive and anti-inflam-matory agent and should be explored further in autoimmune diseases and transplantation [200] . Triptolide inhibited glutamate-induced cell death, ROS formation, and decrease of mitochondrial membrane potential [201] .
Triptolide also has inhibitory effects on a variety of proinflammatory cytokines and mediators and on the expression of adhesion molecules by ECs [200] . Tripolide and the extracts of TWHF are able to inhibit a variety of proinflammatory cytokines and mediators such as IL-1, TNF-, IL-6, and IL-8 linking to the suppression of NF-B [202, 203] . An extract from TWHF has been demonstrated to inhibit the secretion and expression of ICAM-1, VCAM-1, and Eselectin by activated human synovial fibroblast and human umbilical cord veins [204] . Thus anti-inflammatory properties of triptolide are associated with inhibition of NF-B signaling and adhesion molecule expression.
Scutellaria Baicalensis (Baicalien and Wogonin)
The dried roots of Scutellaria baicalensis Georgi have been widely employed for many centuries in traditional Chinese herbal medicine as popular antibacterial and antiviral agents. They are effective against staphylococci, cholera, dysentery, pneumococci, and influenza virus [205] . Baicalein, one of the major flavonoids contained in the dried roots, possesses a multitude of pharmacological activities. The glycoside of baicalein, baicalin is a potent anti-inflammatory and anti-tumor agent. Baicalein is a potent free radical scavenger and xanthine oxidase inhibitor, thus improving endothelial function and conferring cardiovascular protective actions against oxidative stress-induced cell injury [206] . Baicalein lowers blood pressure in renin-dependent hypertension and the in vivo hypotensive effect may be partly attributed to its inhibition of lipoxygenase, resulting in reduced biosynthesis and release of arachidonic acid-derived vasoconstrictor products [207] . Wogonin, another active component of Scutellaria baicalensis, has antioxidant and antiinflammatory properties. Wogonon was found to inhibit MCP-1 induction in ECs; this inhibition is mediated by reducing AP-1 transcriptional activity via the attenuation of ERK1/2 and JNK signal transduction pathways [208] .
The effects of nine flavonoids isolated from Scutellariae Radix on IL-1 -and TNF--induced adhesion molecule expression in cultured HUVECs has been investigated. Among them, baicalein inhibited cytokines-induced E-selectin and ICAM-1 expressions [209] . Another group examined the effects of various flavonoids isolated from the roots of Scutellaria baicalensis Georgi on adhesion molecule expression on HUVECs and found that baicalein inhibited Eselectin or ICAM-1 expression induced by thrombin, thrombin receptor agonist peptide, or PMA. [210] . The pharmacological findings have highlighted the therapeutic potentials of using plant-derived baicalein and its analogs for the treatment of arteriosclerosis and hypertension [211] .
Stephania Tetrandra (Tetrandrine)
Tetrandrine is a benzylisoquinoline alkaloid isolated from the Chinese herb Stephania Tetrandra Radix that has been used as an anti-inflammatory agent both clinically [212] and experimentally [213] . Numerous pharmacological activities have been attributed to the anti-inflammatory effects of tetrandrine. These include the scavenging of oxygen radicals, suppression of neutrophil chemotaxis and phagocytosis [214] , and inhibition of neutrophil and monocyte adhesion [215] .
Tetrandrine could inhibit neutrophilic recruitment, expression of ICAM-1 mRNA, and activation of NF-B [216] . The anti-adherent effect of tetrandrine is found by the inhibition of calcium influx and ROS formation, resulting in suppressed up-regulation of Mac-1 and, in turn, neutrophil adhesion [217] . These potent anti-adhesion molecule properties of tetrandrine may account for some of their potential antiinflammatory effects.
Other Herbal Preparations
The use of traditional medicinal herbs or their pharmaceutical products for disease prevention and management is becoming increasingly popular in Western countries. There are various herbs have been used for the treatment of syndromes clinically overlapping Western cardiovascular syndromes [218] . There are still a large number of herbal preparations with potential to prevent atherogenesis under developing. For example, the roots of Angelica keiskei have traditionally been used as a health food, with diuretic, laxative, analeptic and galactagogic effects. It has been thought that the roots and leaves have preventive effects against coronary heart disease, hypertension, and cancer [219] . Angelica (isolated from Angelica keiskei) has protective effect against oxLDL induced damage and ICAM-1 expression on cultured HUVECs [220] . Hematein is a compound isolated from Caesalpinia sappan that has been used in oriental medicine as both an analgesic and an anti-inflammatory agent. Hematein prevented the up-regulation of the VCAM-1 expression on the descending aorta induced by cholesterol diet. In culture, hematein also significantly inhibited the secretion of soluble VCAM-1 and of MCP-1 respectively induced by TNF-and mildly oxLDL in HUVECs. Also, hematein inhibited monocyte adhesion to ECs and the activation of NF-B in HUVECs stimulated with TNF-. [221] . A crude ethanolic extract of corn silk (stigma of Zea mays), a European antiinflammatory herbal drugs for TNF antagonistic activity, also possesses important therapeutic potential for TNF-and LPS-mediated leukocyte adhesion and trafficking [222] . This information revealed the potential roles of herbal preparations on new drug development for the prevention of cardiovascular diseases.
Dietary Supplements with Antioxidative Property
Green Tea Polyphenols
Increasing number of epidemiological and experimental studies suggest that tea consumption is associated with a reduced risk of coronary artery disease. Evidences showed that antioxidative and anti-inflammatory properties of catechins, the main components of tea, are involved in the prevention of atherogenesis [223] . It has been estimated that catechins constitute as much as 80% of the total flavonoids in green tea and 20-30% in black tea [224] . Epigallocatechin-3-gallate (EGCG), the most abundant and most active catechin derivative, has been reported to possess anti-atherogenic properties in experimental studies [225, 226] . It has been hypothesized that the anti-atherosclerotic activity of catechins is associated with their antioxidative activity. Studies have shown that catechins inhibit the generation of oxLDL, a triggering molecule in the atherogenic process, and prevent the formation of foam cells in atherosclerotic lesions [226, 227] . In addition, tea intake has been shown to decrease the susceptibility of LDL oxidation in humans [228] .
The effects of various tea catechins including epicatechin (EC), epicatechin gallate (ECG), epigallocatechin (EGC), and epigallocatechin-3-gallate (EGCG) on cytokine-induced expression of ICAM-1, VCAM-1, and E-selectin in HUVECs have been investigated. EGCG prevented the induction of VCAM-1 expression after stimulation with TNFand IL-1 . Furthermore, EGCG reduced the TNF--induced adhesion of THP-1 cells to HUVECs [229] . Recently, green tea extract and EGCG have been reported to exhibit a specific and strong anti-STAT1 activity which is independent of their acclaimed strong anti-oxidant activity. Among natural compounds there are a number of anti-STAT1 substances [61] . These data emphasize an important mechanism by which tea catechins may exert anti-atherogenic and anti-inflammatory effects.
Flavonoids (Resveratrol, Quercetin, Apigenin, Genistein, Anthocyanins, Pycnogenol, and Gallates, etc.)
The phytochemistry phenolic compounds plentiful in red wine or plants (including tea and soy) contain various flavonoids (resveratrol, quercetin, apigenin, genistein, anthocyanins, and galloyl compounds, etc) [230, 231] . Epidemiological studies have demonstrated that an increased intake of polyphenolic phytochemicals such as flavonoids, proanthocyanidins, and phenolic acids found in a large number of fruits and vegetables may contribute to the low incidence of cardiovascular diseases in some populations [232] . The effects of several flavonoids will be briefly discussed in the following paragraphs.
Resveratrol
The hydroxystilbene resveratrol (trans-3,4,5-trihydroxystilbene), is found in high concentrations as a natural component of grape seeds and peanut roots [233, 234] . Consequently, resveratrol is the major effector of the cardioprotective properties of red wine [235] . A number of previous studies have also indicated that resveratrol has vasoprotective and anti-inflammatory effects, which appear to be partly responsible for its antioxidant properties [236, 237] . Resveratrol significantly inhibited ICAM-1 and VCAM-1 expression by TNF--stimulated HUVECs and LPS-stimulated human saphenous vein endothelial cells (HSVECs), respectively. In addition, resveratrol induced a significant inhibition in the adhesion of U937 monocytoid cells to LPSstimulated HSVECs [238] .
Quercetin
Quercetin, a plant flavonoid that occurs naturally, is widely distributed in fruits and vegetables such as apples, berries, and onions. It has been estimated that sometimes quercetin may represent as much as 60% of the total flavonoids consumed [239] . Quercetin, related flavonoids, and plant extracts from tea and Ginkgo biloba have been reported to have various clinically relevant properties such as antioxidant [240, 241] , anti-inflammatory [242] , and tumoricidal activity [243] . Furthermore, beneficial associations between the consumption of quercetin and lower incidences of coronary heart diseases and stroke have been reported [244] . Quercetin could inhibit LPS-induced expression of endothelial cell ICAM-1 [245] downregulate both PMA-and TNF--induced ICAM-1 expression via inhibiting AP-1 activation as well as the JNK pathway [246] .
Apigenin
Apigenin, a less-toxic and non-mutagenic flavonoid, suppressed 12-O-tetradecanoyl-phorbol-13-acetate-(TPA)-mediated tumor promotion of mouse skin. Suppression of PKC activity and nuclear oncogene expression might contribute to the molecular mechanisms of inhibition of TPA-induced tumor promotion by apigenin and curcumin [247] . Apigenin is showed to effectively block ICAM-1 upregulation and leukocyte adhesion in response to cytokines [248] . Another report showed that treatment of human ECs with certain hydroxyflavones and flavanols blocks cytokine-induced ICAM-1, VCAM-1, and E-selectin expression; one of the most potent flavones, apigenin, exhibited a dose-and time-dependent, reversible effect on adhesion protein expression. However, apigenin did not inhibit TNF--induced nuclear translocation of NF-B [242] . Apigenin showed potent antiinflammatory and offered important therapeutic potential for the treatment of a variety of inflammatory diseases involving an increase in leukocyte adhesion and trafficking.
Genistein
Genistein, an isoflavone from soy, is an inhibitor of tyrosine-specific protein kinase activity of the epidermal growth factor (EGF) receptor. By contrast, genistein scarcely inhibited the enzyme activities of serine-and threonine-specific protein kinases [249] . The role of tyrosine phosphorylated proteins in the regulation of leukocyte adhesion to ECs has been widely investigated. Genistein was found to significantly inhibit IL-1 and TNF--induced upregulation of neutrophils and monocyte adherence [250] . Induction of ICAM-1, VCAM-1, and E-selectin surface expression by TNF was dose-dependently reduced by pretreatment with the protein tyrosine kinase inhibitors genistein suggesting that specific phosphorylation following protein tyrosine kinase activation may be required for NF-B mobilization and induction of VCAM-1 and ELAM-1 by TNF [251] . Similar results were also been observed in different studies [252, 253] . These findings reveal that tyrosine phosphorylated proteins may regulate leukocyte adherence and cell adhesion molecule expression on the endothelium [254] .
Pycnogenol
Pycnogenol, which is an extract prepared from the bark of the French maritime pine (Pinus maritima), is a unique complex of flavonoids, mainly procyanidins, phenolic acids, and other components. Several studies have elucidated antioxidant as well as anti-inflammatory properties of this extract [255, 256] . Pycnogenol has been studied on the activation of NF-B and the induction of VCAM-1 and ICAM-1 in TNF--treated HUVECs. Pretreatment with pycnogenol exhibited a concentration-dependent suppression of TNF--induced release of superoxide anion and H 2 O 2 and activation of NF-B. Induction of VCAM-1 and ICAM-1 surface expression by TNF-was dose-dependently reduced by pycnogenol suggesting that this phytochemical may play an important role in halting or preventing the atherogenic process [257] .
Anthocyanins
The (pro)anthocyanidins or condensed tannins are a group of biologically polyphenolic bioflavonoids that are synthesized by many plants such as grape seed or cranberry. Proanthocyanidin has also been reported to have various clinically relevant properties such as antioxidant, anti-cancer activity, and prevention of urinary tract infection [258, 259] . The potent inhibitory effect of low concentrations of grape seed proanthocyanidin extract (GSPE) treatment significantly decreased TNF--induced VCAM-1 expression and adherence of T-cells to HUVECs in an NF-B-independent pathway suggesting the therapeutic potential of this extract in inflammatory conditions and other pathologies involving altered expression of VCAM-1 [260] .
Gallates
Gallates (gallic acid esters) belong to the class of phenolic compounds, which are abundant in red wine and tea. It has been showed that gallates can inhibit cytokine-induced activation of NF-B and thereby reduce expression of endothelial adhesion molecules in cultured HUVECs. Ethyl gallate can inhibit cytokine-induced nuclear translocation of NF-B p65 and thereby suppress expression of VCAM-1, ICAM-1, and E-selectin, which was associated with reduced adhesion of leukocytes suggesting that these natural compounds may play important roles in the prevention of atherosclerosis and inflammatory responses in vivo [261] .
Moderate consumption of red wine or dietary supplements has been putatively associated with lowering the risk of developing coronary heart disease. Several studies indicate this beneficial effect is mainly attributed to the occurrence of flavonoids and polyphenol compounds with its antioxidant function. There are still lots of different flavonoids that could not been fully discussed in the article, but all these antioxdative agents revealed the potential roles of the prevention of cardiovascular diseases.
Vitamin C, E, and Other Antioxidants (Carotenoids, -Lipoic Acid, Estradiols, N-Acetylcysteine, Pyrrolidine Dithiocarbamate, etc.)
Vitamin C and E
Reducing the concentration of ROS through the use of antioxidant therapy is a potential mechanism for treating endothelial dysfunction. The group of antioxidant vitamins, C, and E, are therefore uniquely situated to potentially reduce cardiovascular events by improving endothelial function and also by preventing oxidative modification of LDL into the atherogenic oxLDL. Up until now, investigations have focused on dietary antioxidant vitamins, vitamin C, and vitamin E. Pretreatment of HUVECs with vitamin E significantly reduced oxLDL-induced VCAM-1 expression [84] . An inhibitory effect of cellular -tocopherol on IL-1 -induced upregulation of E-selectin and monocyte adhesion to ECs [262] . Recently, -tocopherol enrichment of monocytes was shown to decrease agonist-induced adhesion to ECs [263] . Ascorbic acid was demonstrated to inhibit the TNFinduced expression of ICAM-1 on the HUVECs. It also inhibited the production of NO and H 2 O 2 induced by TNF-, which suggests that the inhibition of ICAM-1 expression may be due to the modulated production of the reactive oxygen/nitrogen components [264] . Until now, Vitamin E and C are uasually considered as antioxidative positive control in various experiments.
Carotenoids are a family of naturally occurring plant pigments that were initially studied due to their role as retinoid precursors. More than 600 distinct carotenoids have been isolated from natural sources [265] . There are five wellcharacterized carotenoids in most blood samples comprising approximately 90% of the total plasma pool of carotenoids. Several large epidemiological studies have shown a correlation between elevated plasma carotenoid levels and decreased risk of cardiovascular disease. One proposed mechanism for the beneficial effect of carotenoids is through functional modulation of potentially atherogenic processes associated with the vascular endothelium. Preincubation of HAECs with -carotene, lutein and lycopene was found to significantly reduce adhesion molecule expression [266] . Retinoic acid (vitamin A derivate) was shown to inhibit the TNF--regulated expression of VCAM-1 by cultured dermal microvascular ECs in an NF-B-dependent pathway [267] .
-Lipoic Acid
The metabolic thiol antioxidant -lipoic acid has been suggested to be of therapeutic value in pathologies associated with redox imbalances. Preincubation of HAEC withlipoic acid dose-dependently inhibited TNF--induced adhesion of monocytic THP-1 cells, as well as mRNA and protein expression of E-selectin, VCAM-1, and ICAM-1 by inhibiting the NF-B signaling pathway [268] . Other studies showed that the -lipoic acid at clinically relevant doses down-regulated PMA [269] -or advanced glycation end products (AGEs) [270] -induced adhesion molecule expression and decreased PMA-induced generation of intracellular oxidants.
In fact, there are a number of various endogenous or synthetic antioxidative agents, such as 17 -estradiol [271] , Nacetylsysteine (NAC), pyrrolidine dithiocarbamate (PDTC) [272] , etc., that could not be completely reviewed without omitting here. These antioxdative agents exhibited the similar potential roles of the prevention of cardiovascular diseases by inhibiting the adhesion molecule expression. Overall, it is indicated that these antioxidants may have a therapeutic potential in the treatment of various inflammatory disorders associated with an increase in endothelial leukocyte adhesion molecules such as that in atherogenesis.
CONCLUSIONS
In this article, we have reviewed serial drugs and agents with antioxidative property that may inhibit endothelial expression of adhesion molecules and/or the endothelial adhesiveness to circulating monocytes either in vitro, in vivo, or ex vivo. The mechanisms of these drugs and agents commonly involve modulation of intracellular redox-sensitive transcriptional pathways that may contribute to leukocyte recruitment and vascular inflammation in term of atherogenesis. The inhibition of vascular as well as endothelial ROS generation has been implicated to attenuating the development and progression of atherosclerosis and its clinical sequella in some particular groups of patients. Since atherosclerosis is a chronic inflammatory process involving multiple complexicities, theoretically, the early administration of the combined treatment with multiple drugs or agents blocking different pathways by different properties may have better clinical impact. Thus, in addition to the current approaches in risk factor modification, further development of a novel therapeutic stratege that inhibits endothelial expression of adhesion molecules by reducing intravascular ROS generation could be of importance in the prevention and treatment of atherosclerotic cardiovascular disease.
